Jupiter Neurosciences (JUNS) EV/EBIT: History & Chart

Jupiter Neurosciences, Inc.(JUNS)

Biotechnology · Jupiter, FL

$2.62+0.20 (+8.27%)

Delayed quote: Oct 6, 2026, 1:03 PM EDT

About Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.

Jupiter, FL

5 employees

jupiterneurosciences.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Christer Rosen

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Jupiter Neurosciences, Inc. (JUNS)	$1.27M	N/A	N/A	N/A	N/A
NewcelX Ltd. (NCEL)vs ›	$1.32M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.34M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.38M	N/A	N/A	N/A	N/A
IM Cannabis Corp. (IMCC)vs ›	$1.16M	N/A	10.71x	10.71x	10.71x
INVO Fertility, Inc. (IVF)vs ›	$1.45M	N/A	N/A	N/A	N/A
NEXGEL, Inc. (NXGL)vs ›	$1.43M	N/A	N/A	N/A	N/A
Propanc Biopharma, Inc. (PPCB)vs ›	$1.14M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.47M	N/A	439.92x	439.92x	439.92x
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.10M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Jupiter Neurosciences, Inc. (JUNS)

$1.27M

N/A

NewcelX Ltd. (NCEL)vs ›

$1.32M

N/A

Genprex, Inc. (GNPX)vs ›

$1.34M